Aim immunotech reschedules investor conference call to january 21, 2021 at 11am et

Aim to discuss amp-511 trial which includes covid-19-induced chronic fatigue “long hauler” patients and other upcoming milestones aim to discuss amp-511 trial which includes covid-19-induced chronic fatigue “long hauler” patients and other upcoming milestones
AIM Ratings Summary
AIM Quant Ranking